“COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE”. Journal Pharmaceutical Science and Application 5, no. 1 (June 1, 2023): 34–44. Accessed September 21, 2026. https://ejournal3.unud.ac.id/index.php/jpsa/article/view/3426.